Hemas Holdings Ltd. · CSELK:HHL.N0000
Hemas — Q1 FY2021-22 Earnings Presentation
25 slides from Hemas's earnings presentation, Aug 17, 2021
Slide 1: Investor Presentation Hemas Holdings PLC Q1 FY 2021–2022
Investor Presentation Hemas Holdings PLC Q1 FY 2021–2022 August 17, 2021
Slide 2: Hemas Holdings PLC: About us
Hemas Holdings PLC: About us Market cap: LKR 48.7 billion (USD 242.0 million) Shareholding structure: Esufally family holds 64.2%, 35.8% public holding. Governance: • HHL is governed by a 9-member board including 3 Independent Directors who are thought leaders in their respective fields. • The
Slide 3: Hemas Journey: 70 years of serving the nation
Hemas Journey: 70 years of serving the nation Ventured into manufacturing Widened array of Extended into Sold N*able + personal care Home & Personal the hospital Sold Power Travel and products care (HPC) brands space Business Aviation Divestment of Serendib Hotels PLC 1948 1970s 2003 2013 2018 1960s
Slide 4: Streamlined and poised for growth: Make Healthful Living Happen
Streamlined and poised for growth: Make Healthful Living Happen We achieved an important milestone in our journey as a Group, with the launch of our purpose, ‘Make Healthful Living Happen’ 4 Copyright © 2020 Hemas Holdings PLC | www.hemas.com
Slide 5: Macro Economic Update
Macro Economic Update Y-o-Y increase in National Consumer Price Index COVID-19 Vaccination Total confirmed 6.1% Vs 2020 Jun % of population Total Deaths 13% cases 2.8 Million 1st Dose 259,089 3,077 1.1 Million 5% 12.8% Vs 2019 Jun 2nd Dose Note: Data from 27th January 2020 to 30th June 2021 Steep LK
Slide 6: Navigating through the COVID-19 pandemic
Navigating through the COVID-19 pandemic Healthcare Consumer Brands Mobility Revenue – Rs. 10.5 Bn Revenue – Rs. 5.4 Bn Revenue – Rs. 0.6Bn EBIT – Rs. 0.8 Bn EBIT – Rs. 0.2 Bn EBIT – Rs. 0.2 Bn • Stable growth was witnessed across • Robust Y-o-Y volume led growth • Increased freight rates positively
Slide 7: Our market leading positions in Consumer and Healthcare enable us to deliver healthful outcomes
Our market leading positions in Consumer and Healthcare enable us to deliver healthful outcomes Group Revenue by Segment* Q1 FY 2021-22 Mobility Other 3.6% 0.0% Sri Lanka’s Largest Pharma Supplier Consumer Market Leading Purposeful HPC 32.6% Partnered with Global Maritime Brands and Logistics Brands
Slide 8: Q1 FY 2021–22 – Group Revenue & Earnings
Q1 FY 2021–22 – Group Revenue & Earnings Group Revenue Group Earnings Q1 FY 19 – Q1 FY 22 Q1 FY 19 – Q1 FY 22 18,000Mn 1,000Mn 16,000Mn 800Mn 14,000Mn 12,000Mn 600Mn 10,000Mn 400Mn 769 8,000Mn 16,404 637 6,000Mn 12,427 12,155 12,942 200Mn 268 4,000Mn 0Mn 2,000Mn (143) 0Mn -200Mn Q1 FY19 Q1 FY20 Q1 F
Slide 9: Q1 FY 2021–22 – Operational Summary
Q1 FY 2021–22 – Operational Summary Sector Revenue & EBIT Margin (%) Revenue of Rs 16.4Bn indicates a Y-o-Y growth of 26.8%, an Q1 FY 19 – Q1 FY 22 improvement of Rs.3.5Bn. All sectors witnessed a steady growth compared to lower 18,000Mn 16,404 10% operating results recorded in Q1 last year due
Slide 10: FY 2021–22 – Quarter-on-Quarter Operational Summary
FY 2021–22 – Quarter-on-Quarter Operational Summary LKR Million Q1 FY 22 vs Q4 FY 21 vs Q1 FY 21 vs Q4 FY 21 Vs Q1 FY 21 Revenue 16,404 -1.1% +26.7% Consumer -8.1% +39.5% Healthcare +4.4% +21.1% Mobility -20.1% +28.7% Consumer -70.7% +554.9% Healthcare +28.5% +29.0% EBIT 1,092 - 17.1% +77.5% Mobilit
Slide 11: Overview: Q1 FY 2021–2022
Overview: Q1 FY 2021–2022 - Industry Overview - Group Operational Highlights - Segment Highlights 11 Copyright © 2020 Hemas Holdings PLC | www.hemas.com
Slide 12: Standing strong and resilient amidst the pandemic
Standing strong and resilient amidst the pandemic Home and Personal Care Industry Healthcare Industry Logistics and Maritime Industry • Extent of the COVID 3rd wave impact • Increased footfall and occupancy at • Passenger travel was impacted due to was lower with better preparedness of hospitals led
Slide 13: Consumer Brands Performance: Q1 FY 2021–2022
Consumer Brands Performance: Q1 FY 2021–2022 Contribution to Group - Q1 FY22 Business Update Revenue % EBIT % Capital Employed % Home and Personal Care Sector witnessed double digit Y-o-Y volume growth across the channels. 33% 20% 28% Margins were under pressure due to rise in commodity prices g
Slide 14: Home & Personal Care: International with our brand Kumarika
Home & Personal Care: International with our brand Kumarika International Segment as a % of total HPC segment Business Update Q1 FY 19 – Q1 FY 22 HPC international segment displays progress in performance in Q1 in 100% comparison to the same quarter last year. 15% 13% 14% 18% Bangladesh 80% HPC
Slide 15: Healthcare Sector Performance: Q1 FY 2021–2022
Healthcare Sector Performance: Q1 FY 2021–2022 Business Update Contribution to Group - Q1 FY22 Revenue % EBIT % Capital Employed % Demand for healthcare products and services has been steady through-out. Pharmaceutical Businesses witnessed improvements in performance in the quarter. 64% 77% 46%
Slide 16: Making brands matter – New product/service launches
Making brands matter – New product/service launches Consumer Brands Healthcare Launched Empagliflozin 25mg Intermediate Care Centers by Hemas Hospitals Fems Aya Baby Cheramy Bamboo Cotton Baby Cheramy Buds Herbal Cologne Atlas e-gift voucher Available at Atlas’s myshop 16 Copyright © 2020 Hemas Hold
Slide 17: Mobility Sector Performance: Q1 FY 2021–2022
Mobility Sector Performance: Q1 FY 2021–2022 Business Update Contribution to Group - Q1 FY22 Maritime Revenue % EBIT % Capital Employed % Y-o-Y TEU volumes handled by the Port of Colombo witnessed a 24% growth. 4% 22% 11% Maritime business continued to face challenges with vessels bypassing Port
Slide 18: Investment Highlights
Investment Highlights Net Debt/EBITDA Return on Equity (%)* Return on Capital Employed (%)* 12.0 10.1 10% 12% 10.0 8.0% 10.5% 8% 6% 10% 8.0 3.7% 4% 8% 6.0 2% 6.1% 6% 4.0 0% 1.7 -2% 4% 2.0 1.1 -4% 2% 0.0 -6% 0.2% Q1 FY 20 Q1 FY 21 Q1 FY 22 -8% -6.9% 0% FY 20 FY 21 FY 22 FY 20 FY 21 FY 22 *Return base
Slide 19: Group Performance: Five-year summary
Group Performance: Five-year summary Group Revenue and % Growth EBIT and EBIT margin (%) Earnings and Earnings margin (%) FY 2017 – FY 2021 FY 2017 – FY 2021 FY 2017 – FY 2021 8 11.0% 12% 4 12% 75 40% 28.5% 9.4%10% 10% 65 6 8.3% 8.8% LKR Billion LKR Billion 30% 8.0% LKR Billion 8% 8% 55 14.9% 5.9% 2
Slide 20: Outlook and priorities; Sustainability
- Outlook and priorities - Sustainability 20 Copyright © 2020 Hemas Holdings PLC | www.hemas.com
Slide 21: Preparing for the next stage in our growth trajectory: Q1 FY 2021-22 priorities
Preparing for the next stage in our growth trajectory: Q1 FY 2021-22 priorities Immediate Priorities Despite the uncertainty related to the extent and length of the third wave, Hemas continues to actively participate in helping the nation fight the pandemic. Hemas has put in place a wide-ranging
Slide 22: Sustainability
Sustainability Sustainability Management Framework Group Environmental Goals and Priorities Reduction of consumption of water by 50% 25% reduction of energy consumption by 2022 and then 50% of energy to be offset by renewable energy Zero waste to landfill Increase and sustain the forest cover in Sri
Slide 23: Sustainability Performance (Q1 2021/22 vs Q4 2020/21)
Sustainability Performance (Q1 2021/22 vs Q4 2020/21)* Carbon Footprint Values of Fines for Non-Compliance (Per Rs. Mn Revenue) with Laws and Regulations in the 0.33 MT Social Economic Area 18% NONE Water Consumption Total Work Related Injury Rate (Per Rs. Mn Revenue) (per 100 employee) 5.1 m3 0.08%
Slide 24: Engaging with Our Community
Engaging with Our Community A private public partnership between the A long term sustainable initiative with the University Hemas Outreach Foundation and the of Kelaniya, Faculty of Medicine Children’s Secretariat of the Ministry of Women and Child Affairs since 2002. • Sri Lanka’s first national ce
Slide 25: Disclaimer
Disclaimer The material in this presentation has been prepared by Hemas Holdings PLC (“Hemas”) and is general background information about Hemas’ activities current as at the date of this presentation. This information is given in summary form and does not purport to be complete. Information in this